![Naratriptan icorandil 4-dichlorophenyl)methyl]amino]-adenosine](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M9317_1621560024.gif?v=1621560025)
Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
4-dichlorophenyl)methyl]amino]-adenosine
2-dicarboxamide
InChi: InChI=1S/C25H34N6O3/c1-17(2)22-16-34-25(33)31(22)23-9-10-26-24(28-23)27-18(3)21-7-5-20(6-8-21)15-29-11-13-30(14-12-29)19(4)32/h5-10
6(2):651-61
Smiles: N[C@@H](CC1C=CC=CC=1)C(=O)N1C/C(=C\C2=CC(Cl)=C(Cl)C=C2)/C(=O)/C(/C1)=C/C1=CC(Cl)=C(Cl)C=C1
Naratriptan icorandil 4-dichlorophenyl)methyl]amino]-adenosineNaratriptan is a selective 5 HT1 receptor subtype agonist for the treatment of migraine headache. Naratriptan binds with high affinity to human cloned 5 HT1B 1D receptors. Migraines are likely due to local cranial vasodilatation and or to the release of sensory neuropeptides (including substance P and calcitonin gene related peptide) through nerve endings in the trigeminal system. The therapeutic activity of AMERGE for the treatment of migraine
US$ 157.00
US$ 314.00
US$ 14.99
US$ 424.50
US$ 319.12
US$ 147.50
US$ 369.31